
    
      The study will investigate immune cell subsets, and how the cells are modified by this
      therapy over a 1-year period in 25 subjects. Blood will be drawn at baseline, 2 weeks, 6 mo,
      and 12 mo.

      Immune subsets will be analyzed by flow cytometry. Data are analyzed with ANOVA with repeated
      measures.
    
  